The efficacy of Shugan Jianpi Zhixie therapy for diarrhea-predominant irritable bowel syndrome: a meta-analysis of randomized, double-blind, placebo-controlled trials.

The efficacy of Shugan Jianpi Zhixie therapy for diarrhea-predominant irritable bowel syndrome: a meta-analysis of randomized, double-blind, placebo-controlled trials.

Shugan Jianpi Zhixie therapy (SJZT) has been widely used to treat diarrhea-predominant irritable bowel syndrome (IBS-D), but the results are still controversial. A meta-analysis of randomized, double-blind, placebo-controlled trials was performed to assess the efficacy and tolerability of SJZT for I...

Full description

Bibliographic Details
Main Authors: Ya Xiao, Yanyan Liu, Shaohui Huang, Xiaomin Sun, Yang Tang, Jingru Cheng, Tian Wang, Fei Li, Yuxiang Kuang, Ren Luo, Xiaoshan Zhao
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4390216?pdf=render

Internet

http://europepmc.org/articles/PMC4390216?pdf=render

Similar Items